News & Articles

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on RNA therapies, immunotherapies, antibody-drug conjugates, and more

The new partnership will aim to advance the development of antigen-targeted EVOC probes for early cancer detection

A new high-quality, cleverly designed liquid handling device can help combat common challenges and accelerate scientific development

New services to support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates

The new Alliance iS HPLC system is aimed at reducing common laboratory errors by up to 40%

Labcon shares how elements found in some filter tip brands may explain unexpected assay failure

Explore the importance of stabilizing temperature in microplate reading technology to achieve robust and reproducible data in your drug discovery workflows

Join industry leaders across Europe in therapeutic drug development to share insights, drive investment, and build new partnerships

Discover how the Seward Stomacher lab blender is designed to reduce cross-contamination and provide compliant, viable test results

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on food safety testing, NGS analysis, spectroscopy techniques, and more

The new partnership hopes to accelerate development of the SPECIFIC REVEAL rapid AST system

The device promises great performance, low price, and short lead time

Optimized for Cytek cell analysis systems; single-tube panel accelerates acute myeloid leukemia (AML) research and MRD detection

Sensirion’s affiliate IRsweep launched the first cost-effective spectrometer product with industry-leading lead times. The new IRis-C is making spectroscopy more accessible for a variety of lab and field applications.

Uniting executives from across the pharmaceutical industry to provide insights into accelerated drug discovery and clinical research through artificial-intelligence.

Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders

Hear from James Grinias, the 2022 winner of the Emerging Leader in Chromatography Award